BORDEAU; Kenneth J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BORDEAU; Kenneth J..The latest application filed is for "crystalline forms".

Company Profile

0.11.10

BORDEAU; Kenneth J. - Kintnersville PA
Bordeau; Kenneth J - Kintersville PA
Bordeau; Kenneth J - Kintnersville PA
Bordeau; Kenneth J. - Kintbersville PA
Bordeau; Kenneth J. - Kintersville PA
Bordeau; Kenneth J. - Upper Black Eddy PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Forms App 20110257190 - BORDEAU; Kenneth J. ; et al.	2011-10-20
3-piperidinylisochroman-5-ols as dopamine agonists Grant 7,919,508 - Shutske , et al. April 5, 2	2011-04-05
Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligands Grant 7,772,252 - Hendrix , et al. August 10, 2	2010-08-10
Novel Heterocyclic Substituted Carbonyl Derivatives and Their Use as Dopamine D3 Receptor Ligands App 20090247509 - Hendrix; James A. ; et al.	2009-10-01
Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligands Grant 7,521,445 - Hendrix , et al. April 21, 2	2009-04-21
2-phenyl-indoles As Prostaglandin D2 Receptor Antagonists App 20070265278 - HARRIS; Keith J. ; et al.	2007-11-15
Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands App 20070161641 - Hendrix; James A. ; et al.	2007-07-12
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands App 20070142351 - Hendrix; James A. ; et al.	2007-06-21
3-piperidinylisochroman-5-ols As Dopamine Agonists App 20070099955 - Shutske; Gregory ; et al.	2007-05-03
Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligands Grant 7,186,724 - Hendrix , et al. March 6, 2	2007-03-06
Heteroarylpiperidines, and their use as antipsychotics and analgetics Grant RE39,265 - Strupczewski , et al. September 5, 2	2006-09-05
Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics Grant RE39,198 - Strupczewski , et al. July 18, 2	2006-07-18
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands App 20050107389 - Hendrix, James A. ; et al.	2005-05-19
Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor App 20040220173 - Hendrix, James A. ; et al.	2004-11-04
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands App 20040030137 - Hendrix, James A. ; et al.	2004-02-12
Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligands App 20030229066 - Hendrix, James A. ; et al.	2003-12-11
1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics Grant RE37,478 - Strupczewski , et al. December 18, 2	2001-12-18
1-(aryloxyalkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics Grant 6,140,345 - Strupczewski , et al. October 31, 2	2000-10-31
3-(heteroaryl)-1-[(2,3-dihydro-1h-isoindol-2-yl)alkyl]pyrrolidines and 3-(heteroaryl)-1-[(2,3-dihydro-1h-indol-1-yl)alkyl]pyrrolidines and related compounds and their therapeutic untility Grant 5,776,963 - Strupczewski , et al. July 7, 1	1998-07-07
N-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-2,3-napthalimides and related compounds and their therapeutic utility Grant 5,571,828 - Strupczewski , et al. November 5, 1	1996-11-05
3-(1-substituted-4-piperazinyl)-1H-indazoles Grant 4,954,503 - Strupczewski , et al. September 4, 1	1990-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.